Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Requirement for myomectomy in women with uterine fibroids after medical treatment
IRCT2015041421653N1Phase 3Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Jul 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of triptorelin in Fibromyoma (LM), sponsored by Jahrom University of Medical Sciences. Primary endpoint: Requirement for myomectomy after treatment. Started Jul 2015; status: completed.
02
Drugs
triptorelin
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT2015041421653N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015041421653N1.